{"name":"Centre for Chronic Disease Control, India","slug":"centre-for-chronic-disease-control-india","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Amlodipine + Indapamide","genericName":"Amlodipine + Indapamide","slug":"amlodipine-indapamide","indication":"Hypertension","status":"marketed"},{"name":"Amlodipine + Perindopril","genericName":"Amlodipine + Perindopril","slug":"amlodipine-perindopril","indication":"Hypertension","status":"marketed"},{"name":"Perindopril + Indapamide","genericName":"Perindopril + Indapamide","slug":"perindopril-indapamide","indication":"Hypertension","status":"marketed"}]}],"pipeline":[{"name":"Amlodipine + Indapamide","genericName":"Amlodipine + Indapamide","slug":"amlodipine-indapamide","phase":"marketed","mechanism":"Amlodipine relaxes blood vessels by blocking calcium channels, while indapamide reduces blood volume and sodium levels through diuretic action, together lowering blood pressure.","indications":["Hypertension","Essential hypertension in patients requiring combination therapy"],"catalyst":""},{"name":"Amlodipine + Perindopril","genericName":"Amlodipine + Perindopril","slug":"amlodipine-perindopril","phase":"marketed","mechanism":"Amlodipine relaxes blood vessels by blocking calcium channels, while perindopril lowers blood pressure by inhibiting angiotensin-converting enzyme (ACE), together reducing hypertension.","indications":["Hypertension","Hypertension in patients with coronary artery disease"],"catalyst":""},{"name":"Perindopril + Indapamide","genericName":"Perindopril + Indapamide","slug":"perindopril-indapamide","phase":"marketed","mechanism":"Perindopril inhibits ACE to reduce angiotensin II formation and lower blood pressure, while indapamide acts as a thiazide-like diuretic to promote sodium and water excretion.","indications":["Hypertension","Hypertension with left ventricular hypertrophy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"pipeline","source":"Indian Pharma Post","summary":"Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore - Indian Pharma Post","headline":"Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE00Znpsb0swOUh6Y25FSGxzOWsyU3FrVWNUSmMzbnA0ZGEyR1ZndVJKa0NVYXRfWVJQd0J5QXpNWHNBSFlYbFEtaTFtRVVxb2hfUFcyS2RaczUyM0s3cEdsWHFUN3ZBY1c1YUhB?oc=5","date":"2026-03-19","type":"pipeline","source":"Pharmabiz.com","summary":"CCDC & University of Leicester rollout £5 million programme to combat the rising cardiovascular burden among older adults in India - Pharmabiz.com","headline":"CCDC & University of Leicester rollout £5 million programme to combat the rising cardiovascular burden among older adult","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"The Times of India","summary":"Centre warns pharma companies against promoting weight-loss drugs among public through ads - The Times of India","headline":"Centre warns pharma companies against promoting weight-loss drugs among public through ads","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQcGpqMVdKSlk2VENmMllZMHBTRDV5WG5BWTVsWFFkV1B4c1ZpR3NHOVVxdG50MWJ5Z3BoLWsyZ0xqa1JBUG1VQlg4bGNpSDUwenRlaXExYVpsM3Y4aTZZcVlLdHUxb3lVNmVaaWNuWFNKSDhfR3lmQzYzczhoa3dKQmdBSkoyTk1JV1Vr?oc=5","date":"2025-10-29","type":"regulatory","source":"The Lancet","summary":"Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiori","headline":"Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (V","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNRFpEbHJIV3dla2pRaWlYQjRITGp0NlNLamFUY0FHYlV6QjJxWWkyLTUyTEVJbTlTd3k0d2tfY1R2R0RrX1BUZnBXYWE4QUZnOTdFYzFtQklkaS1VN2lrcnkyNGZSZWx2aVRkck02Rk9QaWdTZ0ItWTBJMFlYcVk4VDdjZi03cDZ3MUNWaGEyUTFhQ3IzaFJIazgyQTFrSFVuWjM3NDU5TzRnNVhNVlI4ZVhHWmdWVk9kMUhaZ0dlM3F6dlBEZUl4RV9ILWo?oc=5","date":"2025-09-23","type":"pipeline","source":"theindianpractitioner.com","summary":"India’s Silent Health Emergency: Meta-Crisis of Pollution, Chronic Illness and Women’s Health Neglect - theindianpractitioner.com","headline":"India’s Silent Health Emergency: Meta-Crisis of Pollution, Chronic Illness and Women’s Health Neglect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE85M0FXUktLVzQ2R2d0Rm11V2xLeENDRE9PVDhldEpmVG91WDVrTjYtWklPZ0Z6T243c2E3ZXNIUks2eWlxZU90WnBMNndWbHh3cEprZEZKWWx6dVNlSUE4?oc=5","date":"2025-09-18","type":"pipeline","source":"Centers for Disease Control and Prevention | CDC (.gov)","summary":"Who Needs a Flu Vaccine | Influenza (Flu) - Centers for Disease Control and Prevention | CDC (.gov)","headline":"Who Needs a Flu Vaccine | Influenza (Flu) - Centers for Disease Control and Prevention | CDC (.gov)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-25","type":"pipeline","source":"Express Pharma","summary":"Zydus Lifesciences hosts health symposium on new WHO influenza vaccination guideline for Northern Hemisphere 2025-26 - Express Pharma","headline":"Zydus Lifesciences hosts health symposium on new WHO influenza vaccination guideline for Northern Hemisphere 2025-26","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQaUZpZDR2UWxvTjJWNXAxSmpRejN6M1g1LVJ0ak53Y0h6ZnNPcVFJV0ROVWdvQk9ldnpIcnllZFc1aVV5Q2ZjRUZsZXZMUWNGdDRCeVFOM3FPdmRnVTNxaC16Rmg3N3ZSUlFnMHF5RGdPWVFvaFlvcVU0Mm9PakhyU1lrWU5zekVGOW9KbFp0S3BPempMVUdYalRNQnJ4Z1d0ckxNZTlZNTIwR3RCeUpVTmpIWThJTHo4UkJBUmtfTXJUdDRqSjZTd3NDbGZkVk9DT3o3LVhB?oc=5","date":"2025-08-01","type":"pipeline","source":"Reuters","summary":"Trump administration blocks funding for CDC health programs, WSJ reports - Reuters","headline":"Trump administration blocks funding for CDC health programs, WSJ reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"nature.com","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - nature.com","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQcjhZbUMwS2hOaEE2TVpncXZ4RjM2M1JISC1BVld6bllMWmQ3akcwQmNyeHgzUWVhZ2k3QWd2ZW1sbVNHZ3JzLXJwaEFYdnZuQXVOU3oxMkI5RUNFZm9GaDlvLXl2SE5BcTB6VWlJUzNTVzJPaklkSTc4UkV3d1VfOTFDbTBHNTcwU1RHZXhraTRwbTY1NXpiSk1WQXRjTkZmaVlFLXBldUpNN1pQQ294UEtOWFhSaklxa3Qw?oc=5","date":"2025-04-17","type":"patent","source":"fiercehealthcare.com","summary":"Leaked HHS budget signals $40B in cuts, assumes ACA subsidies expire - fiercehealthcare.com","headline":"Leaked HHS budget signals $40B in cuts, assumes ACA subsidies expire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBfQnViSkcyVXdRYm5IQUtPY1ZOLVpHQUpBd3dZNThtaEJhV2RRTVJNYUhDdlZIUThrUG5GRFB5c0Ffa3NDSFhINF9YTGxIOTM1ang5NWlqSHhMMU5UX0NR?oc=5","date":"2024-03-22","type":"pipeline","source":"Every CRS Report","summary":"Centers for Disease Control and Prevention (CDC): History, Overview of Domestic Programs, and Selected Issues - Every CRS Report","headline":"Centers for Disease Control and Prevention (CDC): History, Overview of Domestic Programs, and Selected Issues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOWEhmM25vdV9lZi1xaWNvU2FTX0pFSko0TmNabllHMHh1cDk2WHoxeWxxRHdHN2N5RllEWlM2VHkxZEQ3SHU3bV9FdUJoRHQ2Znl4dk9Gd1B0bEktZVJzMHNSUWlYYWdLeWd3cVVsOTd5NEhBNmJ4TEpUd05mb25KbW9fMmFDQ2RJZXM4SXlMN29KSXBoUlBUS2FCVElXVkE1T2RRWm9lSV9wR1ExM051Wk1FdWFsMWtONTZVb3dYdlJ5TGRqWUd2dQ?oc=5","date":"2023-01-27","type":"pipeline","source":"McKinsey & Company","summary":"The health benefits and business potential of digital therapeutics - McKinsey & Company","headline":"The health benefits and business potential of digital therapeutics - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}